Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Barriers and facilitators to recruitment, engagement, and retention of underrepresented populations in dementia prevention research: a scoping review.

The journal of prevention of Alzheimer's disease·2026

Same author

Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG).

PloS one·2026

Same author

Uniform and reliable assessment of bone union on radiographs in osteotomies around the knee: a novel classification system.

The Knee·2025

Same author

Understanding Indirect Speech in Frontotemporal Dementia and Alzheimer's Disease Dementia: Validation of the Hinting Task - Dutch Version (HT-NL).

Journal of the International Neuropsychological Society : JINS·2025

Same author

Blood Flow Velocity Analysis in Cerebral Perforating Arteries on 7T 2D Phase Contrast MRI with an Open-Source Software Tool (SELMA).

Neuroinformatics·2025

Same author

Increased Intracranial Arterial Pulsatility and Microvascular Brain Damage in Pseudoxanthoma Elasticum.

AJNR. American journal of neuroradiology·2024

Search research articles

Related Experiment Video

Updated: Jul 5, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Cerebral perfusion in relation to cognitive function and type 2 diabetes.

A M Tiehuis¹, K L Vincken, E van den Berg

¹Department of Radiology and Image Sciences Institute, University Medical Center Utrecht, Utrecht, the Netherlands. a.m.tiehuis@umcutrecht.nl

|May 20, 2008

Summary

Type 2 diabetes impairs cognitive function, but reduced cerebral blood flow (CBF) does not explain this decline. Further research is needed to understand the mechanisms behind cognitive deficits in diabetic patients.

More Related Videos

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

Related Experiment Videos

Last Updated: Jul 5, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

Area of Science:

Neurology
Endocrinology
Medical Imaging

Background:

Type 2 diabetes is linked to cognitive decline, but underlying mechanisms remain unclear.
Cerebral hypoperfusion is a known risk factor for cognitive dysfunction and dementia in the general population.
This study investigates if reduced cerebral perfusion contributes to cognitive impairments in type 2 diabetes patients.

Purpose of the Study:

To determine if reduced cerebral blood flow (CBF) explains cognitive impairments in patients with type 2 diabetes.
To compare cognitive performance and CBF between type 2 diabetes patients and healthy controls.
To examine the association between CBF and cognitive function in individuals with and without type 2 diabetes.

Main Methods:

98 type 2 diabetes patients and 47 controls underwent neuropsychological evaluation.
Total cerebral blood flow (CBF) was measured non-invasively using 2D phase-contrast MRI.
Relative total CBF was calculated as CBF per 100 ml of brain parenchyma volume.

Main Results:

Type 2 diabetes patients exhibited worse performance on neuropsychological tests compared to controls (p < 0.05).
No significant difference in relative total CBF was observed between diabetic patients and controls.
Relative total CBF was positively associated with cognitive functioning across all participants, irrespective of diabetes status.

Conclusions:

Reduced cerebral blood flow does not explain the observed cognitive impairments in patients with type 2 diabetes.
While CBF is linked to cognitive function, it does not account for the cognitive deficits seen in this diabetic cohort.
The mechanisms driving cognitive decline in type 2 diabetes require further investigation beyond cerebral perfusion.